Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:846-854, doi:10.1016/j.jcmg.2009.04.009
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Video
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorbala, S.
Right arrow Articles by Di Carli, M. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dorbala, S.
Right arrow Articles by Di Carli, M. F.
Related Collections
Right arrowRelated Article

Incremental Prognostic Value of Gated Rb-82 Positron Emission Tomography Myocardial Perfusion Imaging Over Clinical Variables and Rest LVEF

Sharmila Dorbala, MD*,{dagger},*, Rory Hachamovitch, MD, MSc{ddagger}, Zelmira Curillova, MD*,{dagger}, Deepak Thomas, MD*, Divya Vangala*, Raymond Y. Kwong, MD{dagger}, Marcelo F. Di Carli, MD*,{dagger}

* Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts
{dagger} Noninvasive Cardiovascular Imaging Program, Departments of Medicine (Cardiology) and Radiology, Brigham and Women's Hospital, Boston, Massachusetts
{ddagger} Los Angeles, California


Figure 1
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Event-Free Survival as a Function of Percent Myocardium Abnormal

Kaplan-Meier survival curves showing unadjusted cumulative survival free of cardiac events (CE) as a function of percent myocardium abnormal. Overall survival free of CE was best in the group with 0% abnormal myocardium. Event-free survival worsened with increasing percent abnormal myocardium.

 

Figure 2
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Event Rates in Patients With Normal and Abnormal LVEF Reserve

Annualized rates of cardiac events (CE) (cardiac death and nonfatal myocardial infarction) and all-cause death were lower in patients with left ventricular ejection fraction (LVEF) reserve ≥0% compared to those with LVEF reserve <0%. {dagger}p < 0.001 for CE and all-cause death.

 

Figure 3
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Predicted Event-Free Survival as a Function of Ischemic Burden

The predicted event-free survival as a function of percent myocardium ischemic. The predicted survival (risk-adjusted) free of cardiac events was best in a patient with 0% myocardium ischemic. Survival worsened progressively with 10%, 20%, or 30% myocardium ischemic.

 

Figure 4
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Predicted Event-Free Survival as a Function of Rest LVEF and Ischemic Burden

The risk adjusted predicted survival free of cardiac events in a patient with varying degrees of left ventricular systolic dysfunction and no ischemia (A) or severe ischemia (B). The predicted survival free of cardiac events was best in a patient with an LVEF of 50%. Survival free of cardiac events was worse in a patient with an LVEF of 20% or 35%. For a given LVEF, survival free of cardiac events was worse in a patient with severe ischemia (20% ischemic myocardium, B) compared to a patient with no ischemia (0% myocardium ischemic, A).

 

Figure 5
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Event-Free Survival as a Function of LVEF Reserve

The risk-adjusted survival free of cardiac events in patients with normal and abnormal left ventricular ejection fraction (LVEF) reserve. Risk-adjusted survival free of cardiac events was significantly better in patients with an LVEF reserve of ≥0% compared to those with an LVEF reserve of <0%.

 




Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link